IQVIA banking on new technology that connects legacy Quintiles, IMS resources

While the newly renamed IQVIA (NYSE: IQV) has been busy rolling out the first offering of its integration-focused technology for the commercial side of the pharmaceutical industry, offerings for the clinical side – built with legacy Quintiles resources – are set to follow soon.